Ginsenoside Rg1 induces senescence of leukemic stem cells by upregulating p16INK4a and downregulating hTERT expression.

Autor: Yan-Long Tang, Xiao-Bo Wang, Yue Zhou, Ya-Ping Wang, Ji-Chao Ding
Předmět:
Zdroj: Advances in Clinical & Experimental Medicine; Jun2021, Vol. 30 Issue 6, p599-605, 7p
Abstrakt: Background. Leukemic stem cells (LSCs) play an important role in the pathogenesis of leukemia. This research attempted to clarify effects of the telomere system on ginsenoside Rg1-induced senescence of LSCs. Objectives. This research attempted to clarify effects of the telomere system on ginsenoside Rg1-induced senescence of LSCs. Materials and methods. CD34+CD38-LSCs were isolated, sorted, and divided into a control group and a Rg1 group (treated with 40 µmol/L Rg1). Cell Counting Kit-8 (CCK-8) was used to evaluate cell proliferation, and flow cytometry was used to assess the cell cycle of CD34+CD38-LSCs. The senescenceassociated ß-galactosidase (SA-ß-Gal) staining and CFU-Mix assay were conducted to measure senescence of CD34+CD38-LSCs. The mRNA transcription and protein expression of p16INK4a and human telomerase reverse transcriptase (hTERT) were determined using a real-time polymerase chain reaction (RT-PCR) and western blot assay, respectively. Results. The Rg1 treatment significantly attenuated proliferative activity and decreased the proliferative index (PI) of CD34+CD38-LSCs compared to those of the control group (p < 0.05). It remarkably increased positive SA-ß-Gal staining rate, and suppressed formation of the CFU-Mix of CD34+CD38-LSCs compared with those of the control group (p < 0.05). The Rg1 treatment markedly boosted telomere effector, p16INK4a, in CD34+CD38-LSCs compared with that of control group (p < 0.05). Such treatment obviously reduced telomere regulator, hTERT, in CD34+CD38-LSCs compared with the control group (p < 0.05). Conclusions. Ginsenoside Rg1-induced senescence of CD34+CD38- LSCs through upregulating p16INK4a and downregulating hTERT expression, both of which are associated with telomere systems. The present study would be beneficial for the treatment of leukemia by providing a promising strategy to induce senescence of CD34+CD38- LSCs. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index